Blood platelet count and reactivity are associated with restenosis 6 months after coronary angioplasty

Scandinavian Cardiovascular Journal

Volumn 38, Issue 4, 2004, Pages 211-215

  Johansen, O ^a   Brekke, M ^a   Seljeflot, I ^a   Semb, A G ^b   Arnesen, H ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA ROOT; ARTERY DIAMETER; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY SINUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEMATOCRIT; HUMAN; HUMAN CELL; HYPOTHESIS; INTRAOPERATIVE PERIOD; MALE; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESTENOSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGE DISTRIBUTION; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; FEMALE; HEART CATHETERIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET COUNT; PLATELET-DERIVED GROWTH FACTOR; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 4444225018     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430410035494     Document Type: Article

References (19)

1. Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988; 77: 361-371.
2. Lange RA, Willard JE, Hillis LD. Southwestern internal medicine conference: Restenosis: The Achilles heel of coronary angioplasty. Am J Med Sci 1993; 306: 265-275.
3. Koning R, Eltchaninoff H, Commeau P, et al. Stent placement compared with balloon angioplasty for small coronary arteries: In-hospital and 6-month clinical and angiographic results. Circulation 2001; 104: 1604-1608.
4. Dangas G, Fuster V. Management of restenosis after coronary intervention. Am Heart J 2001; 132: t-36.
5. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM. The pathogenesis of atherosclerosis: An overview. Clin Cardiol 1991; 14 Suppl I: 1-16.
6. Lovqvist A, Emanuelsson H, Nilsson J, Lundqvist H, Carlsson J. Pathophysiological mechanisms for restenosis following coronary angioplasty: Possible preventive alternatives. J Intern Med 1993; 233: 215-226.
7. Chandrasekar B, Tanguay JF. Platelets and restenosis. J Am Coll Cardiol 2000; 35: 555-562.
8. Smyth DW, Martin JF, Michalis L, Bucknall CA, Jewitt DE. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest 2001; 23: 361-367.
9. Tardif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. N Engl J Med 1997; 337: 365-372.
10. Schnyder G, Roffi M, Pin R, et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001; 345: 1593-1600.
11. Okamoto S, Inden M, Setsuda M, Konishi T, Nakano T. Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1992; 123: 1439-1444.
12. Ross R, Bowen-Pope DF, Raines EW. Platelet-derived growth factor and its role in health and disease. Philos Trans R Soc Lond B Biol Sci 1990; 327: 155-169.
13. Johansen O, Brekke M, Seljeflot I, Abdelnoor M, Arnesen H. n-3 fatty acids do not prevent restenosis after coronary angioplasty. Result from the CART study. J Am Coll Cardiol 1998; 33: 1619-1626.
14. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1996.
15. Anonymous. Epi Info 5.01a. In: Epi Info. Version 5.01a. Center for Disease Control Epidemiology Program Office, 1991.
16. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 2001; 79: 1283-1316.
17. Bach R, Jung F, Kobsiek I, et al. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty. Thromb Res 1994; 74 Suppl 1: 55-67.
18. Kotani M, Fukuda N, Ando H, et al. Chimeric DNA-RNA hammerhead ribozyme targeting PDGF A-chain mRNA specifically inhibits neointima formation in rat carotid artery after balloon injury. Cardiovasc Res 2003; 57: 265-276.
19. Fornitz GG, Nielsen P, Amtorp O, et al. Impaired fibrinolysis determines the outcome of percutaneous transluminal coronary angioplasty (PTCA). Eur J Clin Invest 2001; 31: 586-592.